万凌. 腹腔热灌注联合靶向药物化疗治疗恶性腹水的临床护理路径及体会[J]. 实用临床医药杂志, 2014, (4): 33-35. DOI: 10.7619/jcmp.201404011
引用本文: 万凌. 腹腔热灌注联合靶向药物化疗治疗恶性腹水的临床护理路径及体会[J]. 实用临床医药杂志, 2014, (4): 33-35. DOI: 10.7619/jcmp.201404011
WAN Ling. Clinical nursing path and experience of hyperthermic intraperitoneal perfusion combined with targeted drugs chemotherapy in treatment of patients with malignant ascites[J]. Journal of Clinical Medicine in Practice, 2014, (4): 33-35. DOI: 10.7619/jcmp.201404011
Citation: WAN Ling. Clinical nursing path and experience of hyperthermic intraperitoneal perfusion combined with targeted drugs chemotherapy in treatment of patients with malignant ascites[J]. Journal of Clinical Medicine in Practice, 2014, (4): 33-35. DOI: 10.7619/jcmp.201404011

腹腔热灌注联合靶向药物化疗治疗恶性腹水的临床护理路径及体会

Clinical nursing path and experience of hyperthermic intraperitoneal perfusion combined with targeted drugs chemotherapy in treatment of patients with malignant ascites

  • 摘要: 目的 探讨腹腔热灌注联合贝伐珠单抗(安维汀)化疗的护理体会.方法 66例确诊为恶性肿瘤伴腹水患者,灌注前先放尽腹水,以43~45℃的0.9%生理盐水注入腹腔,顺铂30 mg持续有效循环40 min以上,灌液后排尽腹腔液,第2天腹腔内注入贝伐珠单抗100~300 mg和氟尿嘧啶1 g或吉西他滨1 g.结果 全部患者均顺利完成灌注,其中出现不适的患者经对症处理后缓解,并总结出一套腹腔热灌注联合靶向药物化疗的临床护理路径.结论 加强腹腔热灌注化疗患者的护理对于提高治疗效果、减少不良反应有着积极作用.

     

/

返回文章
返回